Votes: US HB383 | 2023-2024 | 118th Congress

Bill Title: To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Spectrum: Partisan Bill (Republican 27-0)

Status: (Introduced) 2023-01-27 - Referred to the Subcommittee on Health. [HB383 Detail]

Text: Latest bill text (Introduced) [PDF]

Voting Records

ChamberVoteDateYeaNayNVAbsTotalResultSourceView
No roll call record information currently on file.
States not producing parsable votes may be available as images in Supplemental Documents.

Social Comments on US HB383

feedback